[sklug] big strides on news - SYGE

yhan na webtv.net yhan na webtv.net
Úterý Únor 5 16:35:12 CET 2002


SYGE announces agreement to beta test the ICU Security System(TM)

Synergetic Technologies, Inc. announced in a press release on Monday February 4th that the company will begin beta testing of its airline security and anti-terrorism system. OTC Investor News has also heard a rumor that the company may be heading into a bulletin board entity in a very short timeframe. Share volume for the past six weeks is reflective of increased business activity and momentum as the stock has gained in price over the past two weeks and the potential for share appreciation seems quite positive.

OTC Investor News believes that immediate near term share appreciation will take place - Here's why:

* OTC Investment News has learned that strong support is coming in from European investors.

* SYGE has recently announced contract negotiations for substantial anti-terrorist system sales - we believe that many more contracts are on their way.

* SYGE recently announced the acquisition of Custom Broadband - completing the technical infrastructure required to deploy the anti-terror system in aircraft.

* OTC Investment News  Believes that a bulletin board listing is imminent. Typically, listing on the BB will enhance the share value.

* SYGE is near the low end of the price spectrum and is seeing record trading volume at this time. OTC Investment News  believes that there will not be a more opportune time to accumulate a position in this company.
***********************************************************
Equity Data for SYGE
Market Capitalization: U.S. $1 Million at current price
Shares Outstanding: 20,152,869 shares issued
Float 2,000,000 (approximate) 
Current Share Price: $0.05
60 Day Target Price $.10
***********************************************************

Conclusion: OTC Investment News  believes that SYGE is well positioned to make a short term run. We are looking at a near term price target of $0.10 and mid term target of $0.18.


OTC Investment News  and its "Report" are not a registered investment advisor, a broker-dealer and/or a broker. All statements and expressions are strictly the opinions of OTC Investment News , the statements and expressions made are not meant to be a solicitation to buy or sell securities. We at OTC Investment News  believe all sources of information to be reliable but make no representation or guarantee to the accuracy of the information provided. The information that OTC Investment News  relies on is, generally provided by the company featured and will also use every attempt possible to include all information available from outside sources. Investors should not only rely solely on the information contained in this publication. Rather investors should use the information provided as a starting point for doing additional research to form his or her opinions. Understand that trading or investing in any securities involves a high degree of risk and use of the information pro!
vided is at the investor's sole risk. Know your risk limitations. OTC Investment News  and its publishers are not liable for any losses, damage's, monetary or otherwise, that may occur due to the content of OTC Investment News  or its Report. The matters in this report contain forward looking statements, as defined in section 27(A) of the securities act of 1933 and section 21(E) of the security exchange act of 1934 as amended. OTC Investment News  may act as a consultant to these companies reviewed in this publication. Investors should be made aware that companies featured might pay consideration to OTC Investment News  and/or it shareholders. OTC Investment News  expects to be paid at least $5000.00 in cash from Marketing Strategies, Inc. for consulting services. OTC Investment News' editor may hold a position in the equity securities profiled in this publication, and may increase or decrease this position at any time.

If you would like to stop receiving this newsletter, email us a remove2002 na xmarketing.org. Type leave the newsletter in the subjcet line.

****




Další informace o konferenci sklug